Transparency - United Kingdom

We believe transparency is an important part of our ongoing collaboration with the health care community, helping to build a community of trust and respect with healthcare professionals, patients, industry peers, stockholders and the public.  

EFPIA

Biogen strongly believes that collaboration with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.

As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations) and the ABPI (Association of the British Pharmaceutical Industry), Biogen is proud to endorse and uphold the EFPIA Disclosure Code and the ABPI Code of Practice disclosure requirements. In line with the codes, Biogen has been collecting all payments and contributions made to HCPs and HCOs since January 2015.

These payments are published on Disclosure UK, the ABPI's disclosure database, on their website.

 

 

 

Biogen-61246    Date of Preparation:  June 2020

Patient Organisation Support

Biogen is proud to work with Patient Organisations and support their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies. Below is a breakdown of the support Biogen has provided to Patient Organisations in the UK.

 

2019

In 2019 Biogen contributed £178,498.15 to UK Patient Organisations.

Patient organisation Project Amount of support
Alzheimer’s Research UK Sponsorship - Dementia Access Taskforce £10,000.00
Alzheimer’s Society Sponsorship - 2018 Annual Conference  £11,038.24
Alzheimer’s Society Sponsorship - 2018 Annual Conference £15,000.00
Genetic Alliance UK Membership - UK Rare Disease Industry Membership £5,000.00
MS Society Sponsorship - MS Frontiers July 2019 £6,000.00
MS Trust Speaker Fee - NMP May 2018 £150.00
MS Trust Speaker Fee - NMP January 2019 £300.00
MS Trust Speaker Fee - NMP January 2019 £742.00
MS Trust Speaker Fee - NMP January 2019 £139.05
MS Trust Sponsorship - Annual Conference 2019  £26,000.00
MS Trust Speaker Fee - Cleo Steering Committee June 2019 £430.00
MS Trust Sponsorship - Annual Conference 2019 £1,500.00
MS Trust Speaker Fee - MS Coordinator Update Meeting October 2019 £433.00
Muscular Dystrophy UK Sponsorship - MD UK Care Advisor Conference  £2,500.00
Muscular Dystrophy UK Sponsorship - Translational Conference April 2019 £5,000.00
SHIFT MS Grant - Relapses 24x24 £20,000.00
SHIFT MS Speaker Fee - Cleo Steering Committee June 2019 £390.00
SHIFT MS

Speaker Fee - MS Advocate Forum £495.00
SHIFT MS

Sponsorship - AM Film £59,000.00
The PSP Association Fee - Project AWA001 £495.00
The PSP Association Travel - Project AWA001 £234.76
The PSP Association Travel - PSP Advocacy Steering Committee Jun 2019 £133.10
The PSP Association Fee - PSP Advocacy Steering Committee Jun 2019 £2,970.00
The Neurological Alliance Fee - Industry Reference Group 2019 £10,548.00

 

 

Biogen-61246    Date of Preparation:  June 2020

Healthcare Professional Support

Biogen strongly believes that collaboration with Healthcare Professionals (HCPs) is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the core of this relationship is the ability to share knowledge in order to improve patient outcomes. At the same time, we believe that Biogen’s interactions with HCPs must be conducted openly and transparently, as embodied by the principles of the EFPIA Disclosure Code and the ABPI Code of Practice.    

To this end, Biogen supports the decision to publically disclose the payments and contributions made to HCPs. By committing ourselves to the highest standards of integrity and accountability, we look to lead our industry in building trust with the communities we serve.

Payments made from 2015 onwards are published on Disclosure UK, the ABPI's disclosure database, on their website.

 

Biogen-61246    Date of Preparation:  June 2020